Cresco Labs (CRLBF) Non-Current Debt (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Non-Current Debt came in at $418.2 million in Q1 2026, little changed on a QoQ basis from $417.1 million in Q4 2025.
Cresco Labs (CRLBF) Non-Current Debt (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Non-Current Debt data on file, last reported at $418.2 million in Q1 2026.
- Quarterly Non-Current Debt changed N/A year-over-year to $418.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $418.2 million (changed N/A YoY) and the FY2025 annual result came in at $417.1 million, changed N/A from the prior year.
- Non-Current Debt steadied at $418.2 million in Q1 2026, from $417.1 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $499.3 million in Q3 2024 to a low of $417.1 million in Q4 2025.
- A 5-year average of $470.7 million and a median of $497.7 million in 2023 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 80.39% in 2022, down 80.39% in 2022.
- Tracing CRLBF's Non-Current Debt over 5 years: stood at $466.1 million in 2022, then grew by 6.79% to $497.7 million in 2023, then climbed by 0.33% to $499.3 million in 2024, then declined by 16.47% to $417.1 million in 2025, then climbed by 0.27% to $418.2 million in 2026.
- The last three Non-Current Debt figures came in at $418.2 million (Q1 2026), $417.1 million (Q4 2025), and $499.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 419.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418.23 Mn |
| Dec 31, 2025 | 417.10 Mn |
| Sep 30, 2024 | 499.33 Mn |
| Jun 30, 2024 | 498.69 Mn |
| Mar 31, 2024 | 498.00 Mn |
| Dec 31, 2023 | 497.71 Mn |
| Mar 31, 2022 | 466.08 Mn |
| Dec 31, 2021 | 465.08 Mn |
| Sep 30, 2021 | 463.86 Mn |
| Mar 31, 2021 | 258.37 Mn |
| Dec 31, 2020 | 255.44 Mn |
| Dec 31, 2019 | 550,000.00 |